Table 2 Results of univariate analysis of clinical, pathological and immunohistochemical parameters related to disease-specific 5-year survival
From: Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
Odds ratio (confidence interval) | P -value | |
|---|---|---|
Patient sex (male vs female) | 1.2 (0.7–2.3) | 0.435 |
Patient ASA classification (0 and 1 vs 2 or 3) | 1.0 (0.5–2.0) | 0.974 |
Patient age (70 and higher vs lower than 70 years) | 1.1 (0.5–2.2) | 0.283 |
Tumour T stage (3 vs 1 and 2) | 4.1 (2.4–7.2) | 0.001 |
Tumour N stage (1 vs 0) | 4.9 (2.8–8.6) | 0.000 |
tumour M1a stage (1 vs 0) | 3.7 (2.2–6.5) | 0.035 |
Differentiation grade (moderate and poor vs good) | 2.2 (1.3–3.6) | 0.015 |
Met expression (high vs low) | 3.5 (2.0–5.9) | 0.000 |
COX-2 expression (high vs low) | 1.4 (0.8–2.6) | 0.234 |
